The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in addition to aneuploidies, as early as nine weeks into pregnancy — ...
The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in addition to aneuploidies, as early as nine weeks into pregnancy - ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する